Galvin Gaustad & Stein’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.9M Buy
145,018
+8,902
+7% +$744K 0.9% 40
2026
Q2
$11.2M Buy
136,116
+8,069
+6% +$647K 0.83% 45
2026
Q1
$9.7M Buy
128,047
+44,358
+53% +$3.46M 0.78% 52
2025
Q4
$6.27M Buy
83,689
+4,457
+6% +$333K 0.49% 62
2025
Q3
$5.83M Buy
79,232
+30,365
+62% +$2.18M 0.47% 62
2025
Q2
$3.46M Buy
48,867
+17,402
+55% +$1.16M 0.3% 68
2025
Q1
$2M Buy
31,465
+2,774
+10% +$174K 0.18% 73
2024
Q4
$1.68M Buy
28,691
+9,168
+47% +$573K 0.15% 80
2024
Q3
$1.29M Sell
19,523
-425
-2% -$27.2K 0.11% 86
2024
Q2
$1.25M Sell
19,948
-2,607
-12% -$163K 0.12% 81
2024
Q1
$1.41M Buy
+22,555
New +$1.35M 0.13% 81

Other funds holding JIRE

Galvin Gaustad & Stein's JIRE Position: Q3 2026 in Review

Galvin Gaustad & Stein increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 6.5% in Q3 2026, buying an estimated $744K and bringing the position to 145,018 shares worth $11.9M. The position accounts for 0.9% of the portfolio, ranked #40.

Galvin Gaustad & Stein first reported a position in JIRE in Q1 2024 and has held it in 11 quarters since. 244 funds tracked by Wall St. Rank hold JIRE as of Q3 2026.

  • Galvin Gaustad & Stein held 145,018 shares of JPMorgan International Research Enhanced Equity ETF worth $11.9M as of Q3 2026.
  • Galvin Gaustad & Stein bought 8,902 JPMorgan International Research Enhanced Equity ETF shares in Q3 2026, an estimated $744K.
  • JPMorgan International Research Enhanced Equity ETF made up 0.9% of Galvin Gaustad & Stein's portfolio in Q3 2026, its #40 holding.
  • Galvin Gaustad & Stein first reported a position in JPMorgan International Research Enhanced Equity ETF in Q1 2024 and has held it in 11 quarters since.
  • 244 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q3 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q3 2026, filed 8 Oct 2026.